Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anisha Ambady

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Bacteriology|July 23, 2014
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivoFrancesca Boldrin, Marcello Ventura, Giulia Degiacomi, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial ActivityManjunatha M R, Radha Shandil, Manoranjan Panda, et al.
ACS Chemical Biology|July 19, 2014
Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coliShahul Hameed P, Praveena Manjrekar, Murugan Chinnapattu, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Assessment of Mycobacterium tuberculosis pantothenate kinase vulnerability through target knockdown and mechanistically diverse inhibitorsB K Kishore Reddy, Sudhir Landge, Sudha Ravishankar, et al.
Journal of Medicinal Chemistry|May 31, 2014
Lead optimization of 1,4-azaindoles as antimycobacterial agentsPravin S Shirude, Radha K Shandil, M R Manjunatha, et al.
Journal of Medicinal Chemistry|November 13, 2013
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivoPravin S Shirude, Radha Shandil, Claire Sadler, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Nature Communications|April 1, 2015
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidateShahul Hameed P, Suresh Solapure, Vikas Patil, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) SynthesisSubramanyam J Tantry, Shankar D Markad, Vikas Shinde, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Bacteriology|July 23, 2014
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivoFrancesca Boldrin, Marcello Ventura, Giulia Degiacomi, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Scaffold Morphing To Identify Novel DprE1 Inhibitors with Antimycobacterial ActivityManjunatha M R, Radha Shandil, Manoranjan Panda, et al.
ACS Chemical Biology|July 19, 2014
Pyrazolopyrimidines establish MurC as a vulnerable target in Pseudomonas aeruginosa and Escherichia coliShahul Hameed P, Praveena Manjrekar, Murugan Chinnapattu, et al.
Antimicrobial Agents and Chemotherapy|April 2, 2014
Assessment of Mycobacterium tuberculosis pantothenate kinase vulnerability through target knockdown and mechanistically diverse inhibitorsB K Kishore Reddy, Sudhir Landge, Sudha Ravishankar, et al.
Journal of Medicinal Chemistry|May 31, 2014
Lead optimization of 1,4-azaindoles as antimycobacterial agentsPravin S Shirude, Radha K Shandil, M R Manjunatha, et al.
Journal of Medicinal Chemistry|November 13, 2013
Azaindoles: noncovalent DprE1 inhibitors from scaffold morphing efforts, kill Mycobacterium tuberculosis and are efficacious in vivoPravin S Shirude, Radha Shandil, Claire Sadler, et al.
Journal of Medicinal Chemistry|May 30, 2014
4-aminoquinolone piperidine amides: noncovalent inhibitors of DprE1 with long residence time and potent antimycobacterial activityMaruti Naik, Vaishali Humnabadkar, Subramanyam J Tantry, et al.
Nature Communications|April 1, 2015
Triaminopyrimidine is a fast-killing and long-acting antimalarial clinical candidateShahul Hameed P, Suresh Solapure, Vikas Patil, et al.
Journal of Medicinal Chemistry|January 12, 2017
Discovery of Imidazo[1,2-a]pyridine Ethers and Squaramides as Selective and Potent Inhibitors of Mycobacterial Adenosine Triphosphate (ATP) SynthesisSubramanyam J Tantry, Shankar D Markad, Vikas Shinde, et al.
Pageof 2